Thema
Journal Article
198
Research Support, Non-U.S. Gov't
79
Peptide Fragments
16
Research Support, N.I.H., Extramural
16
Cytokines
15
Review
13
Conotoxins
11
Glycoproteins
10
Myelin-Oligodendrocyte Glycoprotein
10
RNA, Messenger
10
myelin oligodendrocyte glycoprotein (35-55)
10
Comparative Study
9
Peptides
7
Analgesics
6
Receptors, Nicotinic
6
Research Support, U.S. Gov't, P.H.S.
6
187348-17-0
5
AC6
5
Antineoplastic Agents
5
Biomarkers, Tumor
5
Calcium Channels, N-Type
5
Hepatocellular carcinoma
5
Interleukin-12
5
Lipopolysaccharides
5
Microsatellites
5
NF-E2-Related Factor 2
5
NSCLC
5
STAT3
5
cAMP
5
130068-27-8
4
615
4
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
4
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
4
Antigens, Surface
4
Autosomal dominant inheritance
4
Botulinum Toxins, Type A
4
Botulinum neurotoxin
4
Botulism
4
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
4
Case Reports
4
Cisplatin
4
Cisplatin resistance
4
Disulfides
4
EC 2.7.11.1
4
EC 3.4.24.69
4
EPAS1
4
Electropuncture
4
Genetic variation
4
Hydronephrosis
4
Immunotherapy
4
mehr ...